Amrix Patent Expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8877245 TEVA PHARMS INTL Modified release dosage forms of skeletal muscle relaxants
Nov, 2023

(7 months ago)

US9399025 TEVA PHARMS INTL Modified release dosage forms of skeletal muscle relaxants
Nov, 2023

(7 months ago)

US7790199 TEVA PHARMS INTL Modified release dosage forms of skeletal muscle relaxants
Nov, 2023

(7 months ago)

US9375410 TEVA PHARMS INTL Modified release dosage forms of skeletal muscle relaxants
Nov, 2023

(7 months ago)

US7829121 TEVA PHARMS INTL Modified release dosage forms of skeletal muscle relaxants
Nov, 2023

(7 months ago)

US7544372 TEVA PHARMS INTL Modified release dosage forms of skeletal muscle relaxants
Nov, 2023

(7 months ago)

US7820203 TEVA PHARMS INTL Modified release dosage forms of skeletal muscle relaxants
Nov, 2023

(7 months ago)

US7387793 TEVA PHARMS INTL Modified release dosage forms of skeletal muscle relaxants
Feb, 2025

(7 months from now)



Amrix is a drug owned by Teva Pharmaceuticals International Gmbh. It is used for relieving muscle spasms. Amrix uses Cyclobenzaprine Hydrochloride as an active ingredient. Amrix was launched by Teva Pharms Intl in 2007. It is is available in capsule, extended release form for oral use. Its generic launch date based on the expiry of its last outstanding patent is estimated to be Feb 26, 2025 (This date is subject to change depending upon the patent filing activities by the drug owner or exclusivity additions to its drug application)

Stay ahead of others in designing the generic launch strategy of these 5 blockbuster drugs expiring in next 5 years.

Get the exclusive patent insights now. Don't be the last to know.

Drugs and Companies using CYCLOBENZAPRINE HYDROCHLORIDE ingredient

Market Authorisation Date: 01 February, 2007

Treatment: Relief of muscle spasm

Dosage: CAPSULE, EXTENDED RELEASE

How can I launch a generic of AMRIX before it's drug patent expiration?
More Information on Dosage

AMRIX family patents

Family Patents